Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wijers

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
The American Journal of Pathology|August 11, 2010
Heterogeneous and complex rearrangements of chromosome arm 6q in chondromyxoid fibroma: delineation of breakpoints and analysis of candidate target genesSalvatore Romeo, Ronald A J Duim, Julia A Bridge, et al.
International Journal of Environmental Research and Public Health|April 13, 2023
Evacuation of Refugees from Afghanistan: Health Control at the Spanish Border in the Context of the COVID-19 PandemicMiguel Dávila, Patricia López, Maria Ramiro-Gonzalez, et al.
Genes, Chromosomes & Cancer|July 18, 2024
The Variable Genomic Landscape During Osteosarcoma Progression: Insights From a Longitudinal WGS AnalysisDebora M Meijer, Dina Ruano, Inge H Briaire-de Bruijn, et al.
Neuropsychological Rehabilitation|July 9, 2008
The reliability and validity of the PALOC-s: a post-acute level of consciousness scale for assessment of young patients with prolonged disturbed consciousness after brain injuryH J Eilander, M van de Wiel, M Wijers, et al.
Breast Cancer Research : BCR|November 14, 2007
Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer casesPetra E A Huijts, Maaike P G Vreeswijk, Karin H G Kroeze-Jansema, et al.
Oncotarget|April 21, 2015
Inhibition of mutant IDH1 decreases D-2-HG levels without affecting tumorigenic properties of chondrosarcoma cell linesJohnny Suijker, Jan Oosting, Annemarie Koornneef, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 21, 2025
An Integrated Clinical Genomic and Transcriptomic Subgrouping of Central ChondrosarcomaDebora M Meijer, Sanne Venneker, Baptiste Ameline, et al.
Journal for Immunotherapy of Cancer|January 25, 2024
Multimodal profiling of chordoma immunity reveals distinct immune contexturesSiddh van Oost, Debora M Meijer, Marieke E Ijsselsteijn, et al.
Communications Biology|December 13, 2022
Neutrophil trafficking to the site of infection requires Cpt1a-dependent fatty acid β-oxidationLy Pham, Padmini Komalavilas, Alex M Eddie, et al.
BMJ Oncology|March 6, 2025
Enhanced immune responses are accompanied by increased MAGEA expression in osteosarcoma metastasesDebora M Meijer, Siddh van Oost, Jessica P Roelands, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
The American Journal of Pathology|August 11, 2010
Heterogeneous and complex rearrangements of chromosome arm 6q in chondromyxoid fibroma: delineation of breakpoints and analysis of candidate target genesSalvatore Romeo, Ronald A J Duim, Julia A Bridge, et al.
International Journal of Environmental Research and Public Health|April 13, 2023
Evacuation of Refugees from Afghanistan: Health Control at the Spanish Border in the Context of the COVID-19 PandemicMiguel Dávila, Patricia López, Maria Ramiro-Gonzalez, et al.
Genes, Chromosomes & Cancer|July 18, 2024
The Variable Genomic Landscape During Osteosarcoma Progression: Insights From a Longitudinal WGS AnalysisDebora M Meijer, Dina Ruano, Inge H Briaire-de Bruijn, et al.
Neuropsychological Rehabilitation|July 9, 2008
The reliability and validity of the PALOC-s: a post-acute level of consciousness scale for assessment of young patients with prolonged disturbed consciousness after brain injuryH J Eilander, M van de Wiel, M Wijers, et al.
Breast Cancer Research : BCR|November 14, 2007
Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer casesPetra E A Huijts, Maaike P G Vreeswijk, Karin H G Kroeze-Jansema, et al.
Oncotarget|April 21, 2015
Inhibition of mutant IDH1 decreases D-2-HG levels without affecting tumorigenic properties of chondrosarcoma cell linesJohnny Suijker, Jan Oosting, Annemarie Koornneef, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 21, 2025
An Integrated Clinical Genomic and Transcriptomic Subgrouping of Central ChondrosarcomaDebora M Meijer, Sanne Venneker, Baptiste Ameline, et al.
Journal for Immunotherapy of Cancer|January 25, 2024
Multimodal profiling of chordoma immunity reveals distinct immune contexturesSiddh van Oost, Debora M Meijer, Marieke E Ijsselsteijn, et al.
Communications Biology|December 13, 2022
Neutrophil trafficking to the site of infection requires Cpt1a-dependent fatty acid β-oxidationLy Pham, Padmini Komalavilas, Alex M Eddie, et al.
BMJ Oncology|March 6, 2025
Enhanced immune responses are accompanied by increased MAGEA expression in osteosarcoma metastasesDebora M Meijer, Siddh van Oost, Jessica P Roelands, et al.
Pageof 4